Lindman, H. (2007) “Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer”, Acta Oncologica, 46(2), pp. 165–171. doi: 10.1080/02841860600871087.